IPCA Labs Fact Sheet, IPCA Labs Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA Labs Fact Sheet    (IPLB)


Know More: Is India's Economic Recovery Sustainable?


Here is the latest financial fact sheet of IPCA Labs. For more details, see the IPCA Labs quarterly results and IPCA Labs share price and chart. For a sector overview, read our pharmaceuticals sector report.

IPCA LABS Price History

Price Rs 2,392.0
Mkt Cap Rs m 301,868
Vol '000 95.2
P/E X 31.0
P/CF X 48.3
EPS (TTM) Rs 77.2
% ch % 12.4
No. of shares m 126.20
% ch week % 13.0
% ch 1-mth % 12.0
% ch 12-mth % 153.0
52 week H/L Rs 2,268.0/944.6
(As on Oct 27, 2020 03:36:00 PM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

IPCA LABS Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
IPCA LABS EQUITY SHARE DATA
High Rs8998886436951,042 
Low Rs591629503400590 
Sales per share (Unadj.) Rs249.2230.3254.5260.2298.6 
Earnings per share (Unadj.) Rs20.17.615.419.035.0 
Diluted earnings per shareRs20.17.615.419.035.0 
Cash flow per share (Unadj.) Rs34.420.629.133.149.4 
Dividends per share (Unadj.) Rs1.0001.001.003.00 
Adj. dividends per shareRs1.000.001.001.003.00 
Dividend yield (eoy) %0.100.20.20.4 
Book value per share (Unadj.) Rs174.1179.0194.6213.0247.1 
Adj. book value per shareRs174.1179.0194.6213.0247.4 
Shares outstanding (eoy) m126.20126.20126.20126.20126.35 
Bonus/Rights/Conversions  ----ESOS 
Price / Sales ratio x3.03.32.32.12.7 
Avg P/E ratio x37.099.537.228.923.3 
P/CF ratio (eoy) x21.736.919.716.616.5 
Price / Book Value ratio x4.34.22.92.63.3 
Dividend payout %5.006.55.38.6 
Avg Mkt Cap Rs m94,05795,72372,30069,120103,108 
No. of employees `00013.013.113.313.313.4 
Total wages/salary Rs m5,6516,2566,9607,3597,874 
Avg. sales/employee Rs Th2,416.42,213.32,414.62,477.42,807.0 
Avg. wages/employee Rs Th434.3476.4523.2555.2585.8 
Avg. net profit/employee Rs Th195.473.3146.2180.6329.0 
IPCA LABS INCOME DATA
Net Sales Rs m31,44429,06532,12232,83637,732 
Other income Rs m327222210418577 
Total revenues Rs m31,77129,28732,33233,25438,309 
Gross profit Rs m5,3632,8964,3814,5056,901 
Depreciation Rs m1,7961,6331,7301,7771,824 
Interest Rs m284319241240189 
Profit before tax Rs m3,6111,1662,6212,9055,465 
Minority Interest Rs m00000 
Prior Period Items Rs m-490000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,0192046755111,042 
Profit after tax Rs m2,5429621,9452,3944,422 
Gross profit margin %17.110.013.613.718.3 
Effective tax rate %28.217.525.817.619.1 
Net profit margin %8.13.36.17.311.7 
IPCA LABS BALANCE SHEET DATA
Current assets Rs m19,34816,21917,41819,45523,778 
Current liabilities Rs m12,5179,7009,55910,07610,975 
Net working cap to sales %21.722.424.528.633.9 
Current ratio x1.51.71.81.92.2 
Inventory Days Days10710510098104 
Debtors Days Days7356576766 
Net fixed assets Rs m20,54021,42920,77920,43520,368 
Share capital Rs m252252252252253 
"Free" reserves Rs m21,56422,57824,30026,63330,971 
Net worth Rs m21,96522,59224,55326,88631,224 
Long term debt Rs m4,9874,8433,5172,3401,409 
Total assets Rs m41,24838,91739,59541,17345,507 
Interest coverage x13.74.711.913.130.0 
Debt to equity ratio x0.20.20.10.10 
Sales to assets ratio x0.80.70.80.80.8 
Return on assets %6.93.35.56.410.1 
Return on equity %11.64.37.98.914.2 
Return on capital %14.35.410.210.817.3 
Exports to sales %52.949.248.647.645.9 
Imports to sales %16.715.314.214.916.6 
Exports (fob) Rs m16,62414,29915,61715,64217,308 
Imports (cif) Rs m5,2474,4454,5714,8846,266 
Fx inflow Rs m16,74914,29915,61715,64217,308 
Fx outflow Rs m6,9565,8224,5714,8846,266 
Net fx Rs m9,7938,47711,04610,75911,042 
IPCA LABS CASH FLOW
From Operations Rs m 4,682 7,087 2,819 3,411 4,923 
From Investments Rs m -6,893 -2,183 -1,488 -1,354 -1,563 
From Financial Activity Rs m 2,505 -4,615 -1,591 -1,304 -1,832 
Net Cashflow Rs m 294 288 -260 753 1,528 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 45.9%
Foreign collaborators 0.0%
Indian inst/Mut Fund 11.4%
FIIs 25.3%
ADR/GDR 0.0%
Free float 17.4%
Shareholders 36,892
Pledged promoter(s) holding 2.1%
 

Company Information

REGD OFF 48, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067
E-MAIL investors@ipca.com WEB www.ipca.com
TELEPHONE (022) 6647 4444 FAX (022) 2868 6613
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR Natvarlal Vepari & Co.
CHM: Premchand Godha (MD) COMP SEC: Harish P. Kamath (VP - Legal) YEAR OF INC: 1949 BSE CODE: 524494 FV (Rs): 2 DIV YIELD (%): 0.1

More Pharmaceuticals Company Fact Sheets:   FULFORD INDIA  DR. REDDYS LAB  ALKEM LABORATORIES  LUPIN  ELDER PHARMA  

Compare IPCA LABS With:   FULFORD INDIA  DR. REDDYS LAB  ALKEM LABORATORIES  LUPIN  ELDER PHARMA  

Compare IPCA LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  




Today's Market

Sensex Ends 377 Points Higher; Banking and Finance Stocks Rally(Closing)

After opening the day on a flat note, share markets in India extended gains as the session progressed and ended on a strong note, lifted by gains in financials and FMCG stocks.

Views on news

IPCA LABS Share Price Up by 12%; BSE HEALTHCARE Index Up 1.5% (Market Updates)

Oct 27, 2020 | Updated on Oct 27, 2020

IPCA LABS share price is trading up by 12% and its current market price is Rs 2,394. The BSE HEALTHCARE is up by 1.5%. The top gainers in the BSE HEALTHCARE Index is IPCA LABS (up 11.5%). The top losers are SHILPA MEDICARE and PIRAMAL ENTERPRISES .

THYROCARE TECHNOLOGIES Share Price Up by 5%; BSE HEALTHCARE Index Up 1.5% (Market Updates)

Oct 27, 2020 | Updated on Oct 27, 2020

THYROCARE TECHNOLOGIES share price is trading up by 5% and its current market price is Rs 1,195. The BSE HEALTHCARE is up by 1.5%. The top gainers in the BSE HEALTHCARE Index are THYROCARE TECHNOLOGIES (up 5.1%) and IPCA LABS (up 9.6%). The top losers are ERIS LIFESCIENCES LIMITED (down 0.1%) and SUN PHARMA ADV. RES. (down 0.1%).

IPCA LABS Share Price Up by 7%; BSE HEALTHCARE Index Up 0.1% (Market Updates)

Oct 27, 2020 | Updated on Oct 27, 2020

IPCA LABS share price is trading up by 7% and its current market price is Rs 2,272. The BSE HEALTHCARE is up by 0.1%. The top gainers in the BSE HEALTHCARE Index is IPCA LABS (up 6.5%). The top losers are ALEMBIC PHARMA and DR. LAL PATHLABS (down 0.1%).

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY20); Net Profit Up 22.8% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, IPCA LABS has posted a net profit of Rs 2 bn (up 22.8% YoY). Sales on the other hand came in at Rs 11 bn (up 20.2% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

More Views on News

Most Popular

My View on ITC (Fast Profits Daily)

Oct 23, 2020

What do the charts say about ITC?

Why ITC and not HUL is my Idea of a Good Investment Right Now Views On News (Views On News)

Oct 15, 2020

Rahul Shah discusses HUL's lost decade and its implications for ITC.

Why India's Drone Revolution is a 4x Profit Opportunity (Profit Hunter)

Oct 16, 2020

My research on India's leading defence companies brought me to one major player in drone manufacturing.

The Biggest Wealth Creating Opportunity that No One is Talking About (Profit Hunter)

Oct 14, 2020

The defence sector has gone under the radar despite positive developments. Here's why this sector can't be ignored for long...

More

Covid-19 Proof
Multibagger Stocks

Covid19 Proof Multibaggers
Get this special report, authored by Equitymaster's top analysts now!
We will never sell or rent your email id.
Please read our Terms

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS - JUBILANT LIFE SCIENCES COMPARISON

COMPARE IPCA LABS WITH

MARKET STATS